| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.46B | 36.25B | 33.99B | 35.14B | 34.34B | 34.05B |
| Gross Profit | 11.01B | 10.07B | 9.34B | 9.58B | 9.17B | 8.98B |
| EBITDA | 3.01B | 3.00B | 2.63B | 3.04B | 2.91B | 2.89B |
| Net Income | 1.18B | 1.18B | 1.03B | 1.30B | 1.19B | 1.05B |
Balance Sheet | ||||||
| Total Assets | 33.50B | 31.39B | 26.91B | 26.16B | 25.34B | 23.99B |
| Cash, Cash Equivalents and Short-Term Investments | 4.14B | 3.76B | 3.88B | 3.38B | 3.35B | 3.14B |
| Total Debt | 7.87B | 6.61B | 3.91B | 4.04B | 5.03B | 4.63B |
| Total Liabilities | 14.32B | 12.29B | 8.92B | 9.36B | 9.97B | 9.87B |
| Stockholders Equity | 16.31B | 16.26B | 15.33B | 14.34B | 13.18B | 12.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.46B | 1.18B | 1.28B | 122.76M | 2.11B |
| Operating Cash Flow | 0.00 | 1.41B | 2.01B | 1.90B | 1.17B | 2.54B |
| Investing Cash Flow | 0.00 | -3.93B | -1.11B | -641.81M | -1.01B | -453.17M |
| Financing Cash Flow | 0.00 | 2.40B | -401.21M | -1.23B | 49.79M | -1.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥54.32B | 7.15 | ― | 3.25% | 9.50% | 77.72% | |
73 Outperform | ¥7.34B | 8.56 | ― | 3.20% | 9.49% | 37.09% | |
69 Neutral | ¥12.29B | 18.59 | ― | 1.24% | -2.82% | -44.93% | |
64 Neutral | ¥4.74B | 56.66 | ― | 2.05% | ― | ― | |
63 Neutral | ¥4.73B | 21.80 | ― | 3.79% | -14.22% | -92.98% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | ¥18.18B | 743.26 | ― | 3.24% | -3.73% | -143.19% |